Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 59Squamous Cell Carcinoma of Head and Neck 32Carcinoma, Non-Small-Cell Lung 29Neoplasms 26Head and Neck Neoplasms 26Colonic Neoplasms 20Neoplasm Metastasis 17Rectal Neoplasms 12Breast Neoplasms 11Lung Neoplasms 10Pancreatic Neoplasms 9Carcinoma, Squamous Cell 6Tongue Neoplasms 5Salivary Gland Neoplasms 5Melanoma 5Stomach Neoplasms 4Solid Tumors 4Ovarian Neoplasms 4Carcinoma, Renal Cell 4Advanced Solid Tumor 4Triple Negative Breast Neoplasms 3Sarcoma 3Kidney Neoplasms 3Endometrial Neoplasms 3Advanced Cancers 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Recurrence 2Pharyngeal Neoplasms 2Neoplasms by Site 2

Interventions

Radiation 1Paclitaxel 1Hydroxyurea 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × HPV-Negative Squamous Cell Carcinoma × Cetuximab × Clear all
NCT06005324 2025-06-08

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

University of Chicago

Phase 1 Recruiting
36 enrolled

HPV-Negative Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡